Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000149841 | SCV000616397 | benign | RASopathy | 2017-04-03 | reviewed by expert panel | curation | The filtering allele frequency of the c.81T>C (p.His27=) variant in the HRAS gene is 36.7% for African chromosomes by the Exome Aggregation Consortium (3874/10274 with 95% CI), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert panel for autosomal dominant RASopathy variants (BA1). Additional case-level data provided by: SCV000058315; SCV000062146; SCV000196686. |
Eurofins Ntd Llc |
RCV000038468 | SCV000058315 | benign | not specified | 2017-02-14 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000038468 | SCV000062146 | benign | not specified | 2007-07-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000038468 | SCV000311016 | benign | not specified | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV000509400 | SCV000603967 | benign | not provided | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000659682 | SCV000781528 | uncertain significance | Costello syndrome | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000659682 | SCV001000089 | benign | Costello syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000509400 | SCV001827592 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 32296843, 26607044, 12540507, 21514184, 23150177, 16488657) |
Genome- |
RCV000659682 | SCV001933113 | benign | Costello syndrome | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001813233 | SCV002060519 | benign | Noonan syndrome and Noonan-related syndrome | 2021-07-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002426537 | SCV002679707 | benign | Cardiovascular phenotype | 2018-12-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000509400 | SCV005324601 | benign | not provided | criteria provided, single submitter | not provided | ||
Baylor Genetics | RCV000149841 | SCV000196686 | benign | RASopathy | no assertion criteria provided | clinical testing | Variant classified using ACMG guidelines | |
Genome |
RCV000509400 | SCV000607341 | not provided | not provided | no assertion provided | phenotyping only | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. | |
Faculté Pluridciplinaire Nador, |
RCV001250943 | SCV001250926 | likely benign | Squamous cell lung carcinoma | 2020-05-05 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000038468 | SCV001924805 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000038468 | SCV001972954 | benign | not specified | no assertion criteria provided | clinical testing |